The progress of biomarkers in prostate cancer
10.3760/cma.j.issn.1009-9158.2015.10.003
- VernacularTitle:前列腺癌相关标志物的研究进展
- Author:
Xiuzhi DUAN
;
Zhihua TAO
- Publication Type:Journal Article
- Keywords:
Prostatic neoplasms;
Early diagnosis;
Tumor markers,biological;
Prognosis
- From:
Chinese Journal of Laboratory Medicine
2015;(10):657-660
- CountryChina
- Language:Chinese
-
Abstract:
Affected by many factors such as environment and lifestyle change , prostate cancer has become common malignancy in older men . The introduction and widespread adoption of PSA has revolutionized the way prostate cancer is diagnosed and treated .However , the use of PSA has also led to over-diagnosis and overtreatment of prostate cancer resulting in controversy about its use for screening .PSA also has limited predictive accuracy for predicting outcomes after treatment and for making clinical decisions about adjuvant and salvage therapies .Hence, there is an urgent need for novel biomarkers to supplement PSA for detection and management of prostate cancer .In this review, we discuss the traditional and new relevant molecular markers of early diagnosis and prognosis of prostate cancer for clinical diagnosis and prognosis of prostate cancer providing a reference .
